NAFLD

Exton, Pennsylvania, July 18, 2023 (GLOBE NEWSWIRE) -- Data from the Centers for Disease Control & Prevention (CDC) suggests just over seventy percent of American adults are…

Patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes may…

PRINCETON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac…

Wilmington, Delaware, United States, July 07, 2023 (GLOBE NEWSWIRE) -- The global non-alcoholic steatohepatitis therapeutics market stood at US$ 10.1 billion in 2021 and the global…

Noting that the term "nonalcoholic fatty liver disease" (NAFLD) is…

Madrigal expects to complete full submission of the New Drug Application in July 2023 CONSHOHOCKEN, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a…

First scientific presentation of detailed MAESTRO-NASH results confirms achievement of primary endpoints across multiple patient subgroupsNoninvasive imaging and biomarker data support…

<!-- Name:DistributionId Value:8829412 --> <!-- Name:EnableQuoteCarouselOnPnr Value:True -->…

<!-- Name:DistributionId Value:8828197 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Adding time restriction to a calorie-restricted diet didn't provide any additional benefits…